Given the critical role of ECM remodeling in shaping the tumor microenvironment, promoting tumor invasion, and driving chemoresistance in gastric cancer, COL8A1 emerges as an intriguing therapeutic target worthy of further investigation [77,78]. The gene discussed is COL8A1; the disease is gastric cancer.